Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Adult Malignant Glioma Therapeutics Market from 2024 to 2033?
The adult malignant glioma therapeutics market has grown rapidly, projected to rise from $2.03 billion in 2023 to $2.25 billion in 2024 at a 10.5% CAGR, driven by higher incidence rates, patient advocacy, and personalized treatment advancements.
The adult malignant glioma therapeutics market is expected to grow strongly, reaching $3.23 billion by 2028, at a CAGR of 9.5%. The growth is driven by advancements in immunotherapy, targeted therapies, biomarker discoveries, liquid biopsy applications, and expanded access programs. Trends include patient-centric drug development, fast-track and breakthrough designations, advances in drug delivery systems, collaborative research, and AI integration.
Claim Your Free Sample of the Global Adult Malignant Glioma Therapeutics Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13178&type=smp
What Key Factors Are Fueling the Growth of the Adult Malignant Glioma Therapeutics Market?
The rising incidence of brain tumors is expected to contribute to the growth of the adult malignant glioma therapeutics market. A brain tumor is an abnormal growth of tissue where the usual regulatory systems governing cell growth fail, causing uncontrolled cell multiplication. Adult malignant glioma is a type of brain tumor consisting of abnormally growing cells. Treatment for adult malignant glioma typically involves a combination of surgery, radiation therapy, and chemotherapy. For instance, in January 2023, the American Cancer Society reported an increase in brain and nervous system cancer cases to 24,810 in 2023, marking a 3.85% rise from 23,890 in 2020. This surge in brain tumor cases is expected to drive the growth of the adult malignant glioma therapeutics market.
What Are the Major Segments of the Adult Malignant Glioma Therapeutics Market?
1) By Type Of Disease: Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma, Other Types
2) By Therapy: Chemotherapy, Targeted Therapy, Radiotherapy, Other Therapies
3) By End-User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers, Other End Users
What New Trends Are Transforming the Adult Malignant Glioma Therapeutics Market?
Companies in the adult malignant glioma therapeutics market are developing small-molecule targeted degraders to offer effective treatments. In February 2023, Beactica Therapeutics AB received orphan drug designation from the U.S. FDA for BEA-17, a small-molecule targeted degrader designed to treat glioblastoma (GBM). BEA-17 targets the epigenetic enzyme LSD1 and its co-factor CoREST, promoting tumor suppressor gene activation and inhibiting cancer cell growth.
Order Now for Fast Delivery of Your Adult Malignant Glioma Therapeutics Market Report!
Which Regions Are Driving Growth in the Adult Malignant Glioma Therapeutics Market?
North America was the largest region in the adult malignant glioma therapeutics market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adult malignant glioma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Adult Malignant Glioma Therapeutics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the adult malignant glioma therapeutics market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Adult Malignant Glioma Therapeutics Market Include
1. Adult Malignant Glioma Therapeutics Market Executive Summary
2. Adult Malignant Glioma Therapeutics Market Segments
3. Adult Malignant Glioma Therapeutics Market Size And Template Market Growth Rate
4. Key Adult Malignant Glioma Therapeutics Market Trends
5. Major Adult Malignant Glioma Therapeutics Market Drivers
……
25. Key Mergers And Acquisitions In The Adult Malignant Glioma Therapeutics Market
26. Top Adult Malignant Glioma Therapeutics Companies
27. Adult Malignant Glioma Therapeutics Market Opportunities And Strategies
28. Adult Malignant Glioma Therapeutics Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Digital Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/digital-therapeutics-global-market-report
Leukemia Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/leukemia-therapeutics-global-market-report
Liver Diseases Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
